Call Today for a FREE Case Consultation
Girardi Keese 800.401.4530

Avandia lawsuit settled for $229 million

Last year, GlaxoSmithKline settled an Avandia lawsuit brought by the majority of U.S. states. The states alleged that Glaxo was guilty of healthcare fraud because it marketed products for uses unapproved by the U.S. Food and Drug Administration and failed to provide adequate safety data to the FDA regarding Avandia. Glaxo accepted criminal responsibility and settled for $3 billion.

Eight states, however, refused to sign off on the settlement agreement. Those states recently settled their Avandia lawsuit with GlaxoSmithKline for $229 million. Unfortunately, like the earlier settlement, Glaxo has been able to avoid admitting liability for its actions that have harmed thousands of individuals.

Avandia is a type 2 diabetes drug that has been linked to heart attacks, strokes, coronary artery blockage and other cardiovascular conditions. Due to the number of "adverse events" experienced by individuals using the drug, the FDA put significant restrictions on the U.S. sale and market of Avandia in 2010. This year, however, the FDA relaxed those restrictions.

If you have been harmed by Avandia, the government's lawsuit does not prevent you from bringing your own lawsuit against the company. You may be able to recover compensation for your injuries while holding Glaxo accountable for its significant drug defects.

Source: Reuters, "Glaxo to pay $229 million to settle suits with 8 states," July 24, 2013

No Comments

Leave a comment
Comment Information
FindLaw Network

Privacy Policy | Business Development Solutions by FindLaw, a Thomson Reuters business.